相关实验视频

Updated: Jul 14, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

马拉特1的表达与惰的B细胞瘤中的攻击性行为有关

Elena María Fernández-Garnacho¹, Ferran Nadeu^1,2, Silvia Martín¹

¹Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.

Scientific reports

|October 6, 2023

概括

高MALAT1长非编码RNA表达在惰的B细胞新生瘤中,如慢性淋巴细胞白血病 (CLL) 和卵泡淋巴瘤 (FL),与更具侵略性的疾病和更短的无治疗生存时间相关.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
在RNA生物学,RNA生物学.

背景情况:

马拉特1长非编码RNA (lncRNA) 具有致癌性,但在惰的B细胞瘤中仍未得到充分研究.
了解MALAT1的作用对于推进这些血液恶性瘤的诊断和治疗至关重要.

研究的目的:

研究慢性淋巴细胞白血病 (CLL) 和卵泡淋巴瘤 (FL) 中MALAT1的表达和临床意义.
探索MALAT1与性B细胞瘤的预后因素和疾病病理生理学的关联.

主要方法:

在CLL (n=266),里希特转换 (RT,n=6) 和FL (n=61) 的初级样本中使用RNA测序,微阵列和qRT-PCR分析了MALAT1表达.
与临床参数相关的MALAT1水平,包括治疗时间和无进展生存率.
研究了CLL中共同表达的基因,以确定相关的瘤性途径.

主要成果:

周围血液中CLL样本中的高MALAT1表达与治疗时间缩短有关,独立于其他预后因素.
在外周血液和淋巴结样本中,CLL中的MALAT1水平与外周血液和淋巴结样本相似,这表明微环境信号的反射.
在卵泡淋巴瘤中,MALAT1表达升高预测了较短的无进展生存期.
与CLL相比,里希特转换样本中的MALAT1表达率较低.

结论:

马拉特1的表达与B细胞瘤的病理生理学和侵略性临床行为有关.
在CLL中,MALAT1可以作为微环境刺激的替代标记物,可能有助于精细的临床管理.
马拉特1值得进一步研究,因为它是B细胞瘤的预后和潜在治疗点.

更多相关视频

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...